MedTrace Logo

Polycystic Kidney Disease 1 (PKD1) Gene Variant Groups in Autosomal Dominant Polycystic Kidney Disease

NCT06747572 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 401

Last updated 2026-04-22

No results posted yet for this study

Summary

The purpose of this study is to estimate the prevalence, demographic, and clinical characteristics of PKD1/2 gene variant groups in the ADPKD population.

Conditions

  • Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Sponsors & Collaborators

Eligibility

Min Age
12 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-12-19
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States
  • Belgium
  • Canada
  • France
  • Germany
  • Netherlands
  • Puerto Rico
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06747572 on ClinicalTrials.gov